Sign In
Free Newsletter
Justices reject Frosh’s bid to save generic drugs law
The U.S. Supreme Court on Tuesday rang a death knell for a Maryland law aimed at preventing unwarranted price increases of generic drugs. The justices let stand without comment a 4th U.S. Circuit Court of Appeals decision that the state’s effort to regulate generic drug transactions occurring outside the state violates the Constitution’s Commerce Clause. […]
Frosh presses states’ rights in drug-pricing appeal
In his final bid for Supreme Court review and restoration of a state law aimed at preventing price gouging, Maryland Attorney General Brian E. Frosh urged the justices Friday to hold that states may protect their residents from unwarranted price increases for generic drugs, even if those costs are set out of state. Frosh’s high […]
Hopkins professors urge justices to hear generic drugs appeal
Two Johns Hopkins medical school professors are urging the U.S. Supreme Court to revive a Maryland law aimed at preventing unwarranted price increases for generic drugs, calling access to affordable pharmaceuticals “a crucial issue for the public health.” In papers filed with the justices, Gerard F. Anderson and Joshua M. Sharfstein said the significant presence […]
Justices show interest in Frosh’s generic-drugs appeal
The Supreme Court is showing an interest in Maryland Attorney General Brian E. Frosh’s request that the justices revive the state’s law aimed at preventing unwarranted price increases for generic drugs. On Tuesday the high court asked that the generic-drug industry group challenging the law respond by Dec. 13 to the attorney general’s petition for […]
Generics industry waives response to Frosh’s Supreme Court appeal
A generic-drug industry group will wait to be asked by the U.S. Supreme Court before responding to Maryland Attorney General Brian E. Frosh’s request that the justices revive the state’s law aimed at preventing unwarranted price increases for the pharmaceuticals. In a form filed Monday with the high court, the Association for Accessible Medicines — […]
Frosh takes generic drug price-gouging appeal to Supreme Court
Maryland Attorney General Brian E. Frosh on Friday urged the U.S. Supreme Court to revive the state’s law aimed at preventing unwarranted price increases of generic drugs.
4th Circuit lets generic drug price-gouging ruling stand
The full 4th U.S. Circuit Court of Appeals on Tuesday refused to disturb a three-judge panel’s decision striking down as unconstitutional Maryland’s law aimed at preventing unwarranted price increases of generic drugs, leaving the state with little options other than to seek review by the U.S. Supreme Court.
Supreme Court’s sales tax ruling makes case for Md. drug-price controls, Frosh says
The U.S. Supreme Court’s decision last week permitting states to impose sales taxes on online purchases should save a legally embattled Maryland law aimed at preventing excessive price increases by the generic-drug industry, according to the state attorney general’s office.
Generic-drug industry tells 4th Circuit to let price-gouging ruling stand
Generic-drug makers and distributors have urged the full 4th U.S. Circuit Court of Appeals to let stand a three-judge panel’s decision last month striking down as unconstitutional Maryland’s law aimed at preventing unwarranted price increases by their industry.
4th Circuit strikes down Md.’s generic drug price-gouging law
A divided federal appeals court Friday struck down a Maryland law designed to prevent unwarranted price increases by the generic-drug industry, saying the statute unconstitutionally encroaches on Congress’ province to regulate interstate commerce.
